PaxMedica logo.jpg
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
March 13, 2024 08:20 ET | PaxMedica, Inc.
TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
February 08, 2024 15:30 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Deep Brain Stimulation Devices Market to Witness USD 3.5 Billion Expansion by 2033, Driven by Surging Demand and Ongoing Research Advancements
January 11, 2024 06:55 ET | Market.Us
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- According to market.us, the Deep Brain Stimulation Devices Market is expected to reach around USD 3.5 Billion by 2033, indicating substantial growth...
PaxMedica logo.jpg
PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
November 17, 2023 08:00 ET | PaxMedica, Inc.
LOS ANGELES, Nov. 17, 2023 (GLOBE NEWSWIRE) -- via IBN –PaxMedica, Inc. (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announces that...
Emergen logo.png
Nerve Repair and Regeneration Market Size Worth USD 14.21 Billion in 2032 | Emergen Research
November 15, 2023 12:55 ET | Emergen Research
Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The global Nerve Repair and Regeneration Market will be worth USD 14.21 Billion by 2032, according to a current analysis by Emergen Research. The growth...
PaxMedica logo.jpg
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
October 31, 2023 08:00 ET | PaxMedica, Inc.
TARRYTOWN, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
October 13, 2023 09:30 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Vantage Market Research.png
Synthetic Cannabinoids Market Size & Share to Surpass $6.7 Billion by 2030 | Vantage Market Research
August 29, 2023 07:36 ET | Vantage Market Research
WASHINGTON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Synthetic Cannabinoids Market has been steadily growing over the years due to increasing demand for...
Zion Market Research.jpg
Global Synthetic Cannabinoids Market Size Revenue Forecasted to Surpass $12.4 Billion by 2030, At a CAGR of 21.81%
August 21, 2023 07:20 ET | Zion Market Research
New York, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Synthetic Cannabinoids Market By Indication (Nausea/Vomiting, Pain Management, And...
GMILogo_Vertical-Gradient.png
Central Nervous System Therapeutics Market to hit USD 238.8 billion by 2032, says Global Market Insights Inc.
August 20, 2023 20:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Aug. 20, 2023 (GLOBE NEWSWIRE) -- Central Nervous System Therapeutics Market size is expected to be worth USD 238.8 billion by 2032. The growing investments in R&D...